Many Austrians have never heard of fatty liver disease, but up to 30% suffer from this precursor to liver cancer. Fatty liver disease has become a common disease due to the usual risk factors that characterize the lifestyle in industrialized nations: obesity, lack of exercise and unhealthy diet with too much sugar.
More than 600.000 people suffer from diabetes in Austria and every third person is not yet aware of that metabolic disease. Even a greater number of the population is seriously overweight, which underlies many age-related diseases including development of type II diabetes. Preventive medications and detailed understanding to avert these diseases are therefore an important health issue.
Emilio Casanova contributed to a recent manuscript demonstrating that STAT3 protects from cholestatic liver injury. Specific ablation of STAT3 in liver cells aggravated liver damage and fibrosis in a mouse model for cholestatic disease. Upregulation of bile acid biosynthesis genes and downregulation of epidermal growth factor receptor (EGFR) expression were observed, the functional consequences of these processes in cholestatic liver injury remained unclear.
Richard Moriggl contributed to a recent publication in oncotarget demonstrating that sustained activation of STAT5 induced by Bcr-Abl in chronic myeloid leukemia (CML) cells promotes production of reactive oxygen species (ROS) by repressing expression of two antioxidant enzymes, catalase and glutaredoxin-1(Glrx1). Downregulation of catalase and Glrx1 expression was also observed in primary cells from CML patients.
Researchers from the LBI and the University Vienna now made a fast and simple tool for the assessment of RNA-Seq normalization strategies avaialble. They describe their approach in a recent paper in the journal bioinformatics.
Casanova contributed to a paper by Erhard Hofer of the Medical University of Vienna entitled: Maintenance therapy with histamine plus IL-2 induces a striking expansion of two CD56bright NK cell subpopulations in patients with acute myeloid leukemia and supports their activation, which was published in Oncotarget